VHYSO2 Self-Funding Instalment MINI Announces AUD 0.406508 Unfranked Distribution, Loan Balance Reduced to $37.2864

Implications of the AUD 0.406508 Unfranked Distribution for VHYSO2 Investors

Citigroup Global Markets Australia Pty Limited has confirmed that the VHY CitiFirst Self-Funding Instalment MINI (VHYSO2) will distribute AUD 0.406508 per unit as an unfranked amount. Unlike typical ETF or share dividends, this distribution is not paid in cash but is applied directly to reduce the outstanding loan balance within the instalment warrant, as detailed in section 1.1 of the Product Disclosure Statement (PDS).

This approach is characteristic of Self-Funding Instalment (SFI) products, where distributions serve to decrease the Debt portion of the instalment, thereby increasing the holder’s net Equity over time. For VHYSO2 holders, this distribution reduces the loan from $37.6841 to $37.2864 per unit, a decline of about $0.3977, closely reflecting the declared distribution after adjustments.

Alignment of VHYSO2’s Record and Ex-Distribution Dates with VHY ETF

The update confirms VHYSO2’s distribution dates are synchronized with those of the underlying Vanguard Australian Shares High Yield ETF (ASX:VHY). The record date for entitlement is 2 July 2026, identical to VHY’s record date, and the ex-distribution date is 1 July 2026, matching the ETF’s ex-date.

This synchronization reflects the design of CitiFirst Self-Funding Instalment MINIs, linking the instalment’s economic performance to the underlying security. Distributions from VHY flow through to VHYSO2’s loan reduction mechanism concurrently with VHY’s own distributions. Investors holding VHYSO2 on the 2 July 2026 record date will have the distribution applied to their loan balance, whereas those acquiring the warrant after 1 July 2026 will not receive this distribution.

Mechanics of the Self-Funding Instalment Loan Reduction

Self-Funding Instalments are leveraged investment products issued over listed securities or ETFs. When purchasing an SFI, investors gain upside exposure to the underlying asset while a loan from the issuer—here, Citigroup Global Markets Australia—finances part of the purchase price. The investor pays an initial instalment, with the remainder held as a loan balance that accrues interest but is offset by distributions from the underlying asset.

For VHYSO2, the loan was previously $37.6841 per unit. Applying the AUD 0.406508 distribution as a loan repayment reduces the balance to $37.2864 per unit. This "self-funding" feature means distributions from the high-yield underlying ETF service and gradually reduce the debt, lowering the investor’s Leverage without requiring additional cash.

Underlying Asset: Vanguard Australian Shares High Yield ETF

VHYSO2’s underlying asset is the Vanguard Australian Shares High Yield ETF (ASX:VHY), managed by Vanguard Investments Australia. This ETF tracks an index of Australian shares selected for higher forecast Dividend yields and regularly distributes income from its portfolio of high-yield equities, which flows through to SFI products like VHYSO2.

The size and frequency of these distributions vary with dividends paid by VHY’s holdings. Consequently, the rate at which VHYSO2’s loan balance decreases depends on VHY’s dividend payments. The announcement does not provide forecasts for future distributions.

Paul Kedwell Confirms Final Distribution for VHYSO2

Paul Kedwell, Warrants and Structured Products Manager at Citigroup Global Markets Australia Pty Limited, signed the update confirming the final distribution amount of AUD 0.406508. This confirmation distinguishes the final figure from any earlier estimates. Typically, issuers announce preliminary distribution amounts before the record date and confirm final amounts after the underlying ETF declares its distribution.

The announcement was addressed to ASX Warrants, Level 6, 20 Bridge Street, Sydney NSW 2000, and issued on 2 July 2026. Citigroup Global Markets Australia holds an Australian Financial Services Licence (AFSL 240992) and is a participant of both the ASX Group and Cboe Australia, underscoring its regulatory compliance as an issuer of exchange-traded warrant products in Australia.

Distribution Franking Status and Tax Implications

The VHYSO2 distribution is unfranked, meaning it carries no franking credits that represent tax already paid at the corporate level. Consequently, investors receive no associated franking Credit benefits from this distribution.

Because the distribution reduces the loan balance rather than being paid in cash, tax treatment may differ from standard cash dividends. Investors should consult qualified tax advisers to understand the tax implications specific to their circumstances. The company update does not offer tax advice.

VHYSO2 Within Citigroup’s CitiFirst Structured Products Suite

VHYSO2 is part of Citigroup’s CitiFirst range of structured investment products on the ASX, which includes Self-Funding Instalments, Trading Warrants, Turbos, MINIs, and standard Instalments. These products provide leveraged or instalment-based exposure to various underlying Assets such as equities, ETFs, indices, and commodities. The "MINI" label identifies a specific product type within the SFI category.

Citigroup Global Markets Australia is a leading issuer of structured products in Australia. Regular distribution announcements like this are key to managing the lifecycle of SFI products, ensuring holders and Market Participants have access to updated loan balances and accurate information on the product’s Economics.

Post-Distribution Considerations for VHYSO2 Investors

After this distribution reduces the loan balance to $37.2864, VHYSO2 investors may want to reassess their holdings relative to the current Market Price of the underlying VHY ETF. The critical metric is the difference between VHY’s Market Value and the outstanding loan, representing the instalment’s Intrinsic Value. As loan balances decline through distributions, the investor’s equity stake increases, assuming other factors remain constant.

The next distribution from VHY will trigger another loan reduction cycle for VHYSO2, though no details or timing were provided in this announcement. Investors should monitor VHY’s distribution schedule and future CitiFirst updates for upcoming distribution information. The immediate impact on VHYSO2’s warrant price is unclear, as pricing also depends on time value, Interest Rate expectations, and the underlying ETF’s price.

Summary of Important VHYSO2 Distribution Dates

The ex-distribution date for VHYSO2 was 1 July 2026, meaning trading from that date excluded entitlement to this distribution. The record date was 2 July 2026, aligning exactly with VHY ETF’s dates to maintain the pass-through distribution structure.

Holders on the 2 July 2026 record date will see their loan balance adjusted to $37.2864, reflecting the AUD 0.406508 unfranked distribution. Buyers on or after 1 July 2026 will retain the previous loan balance of $37.6841 for this cycle, as they are not entitled to the distribution. This distinction is crucial for accurate valuation and accounting. Investors should consult the VHYSO2 Product Disclosure Statement for full details on loan adjustment mechanics.